< Back to latest news & events

Event

Translational Microbiome Conference 2020

April 2020

Event date: 24th April 2020

Translational Microbiome Conference 2020 will be hosted on 21-24 April. It will bring together the leading microbiome companies working to successfully commercialise microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products across a range of therapeutic areas, from gut to skin and beyond.

The conference will focus on the challenges and hurdles that companies working in the microbiome space will have to recognise and navigate in order to successfully commercialise their products.

HGF Partner Craig Thomson will be hosting a panel discussion:

Getting your bugs in a row: preparing your IP for investment

Intellectual Property (IP) is only one of the things that investors look at when deciding to invest. How important is IP to investors? What questions can you expect to be asked of your IP? We will also explore what can be done in advance to make it easier to clearly and efficiently demonstrate to investors that your IP adequately underpins the business seeking investment (and how this can be done when funds are tight). The panel will consist of investors, microbiome professionals that are experienced at obtaining large and small level investments, and those that have assisted investors to review IP portfolios as part of pre-investment due diligence.

Attendees

Latest updates

HGF Ranked #1 in the UK for Trade Mark Portfolios in the 2025 Trade Mark Filing Trends Report by Clarivate.

HGF has achieved the #1 ranking for the UK for trade mark portfolios in the newly released 2025 Trade mark Filing Trends report by Clarivate, recognising the firm as a …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

The Enlarged Board of Appeal has today issued its decision in seminal case G1/24.

G1/24, described as one of the most important cases in decades, relates to how claims of patents are to be interpreted by the Boards of Appeal and, by extension, all …

Read article

UPC’s Hamburg Local Division provides guidance on the extent to which a patent may be used as its own “lexicon”

Agfa NV v Gucci & Anors. [UPC_CFI_278/2023] – Hamburg Local Division of the UPC (Klepsch, Schilling, Sarlin) – 30 April 2025 While we await a decision on G1/24 from the …

Read article

MevoCem Nominated for the Earthshot Prize by CIPA

We’re delighted to share that our client, Material Evolution, has been nominated by the Chartered Institute of Patent Attorneys (CIPA) for the globally renowned Earthshot Prize, in recognition of their …

Read article

Agritech Thymes: Agritech 2030: Forecasting the Technologies Poised to Transform Farming

Whilst yet to recover to the levels of 2011-2021, where capital invested in agritech increased 20-fold, investor funding in agritech is starting to pick up, and 2025 is set to …

Read article

UPC delivers first judgment on Validity and Infringement of a Second Medical Use Claim

Sanofi Biotechnology SAS & Anor v Amgen, Inc., & Ors– Thomas, Thom, Kupecz and Dorland-Galliot – [UPC_CFI_505/2024] The Dusseldorf Local Division (LD) has delivered the UPC’s first Judgment on second …

Read article